- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Management of isocitrate dehydrogenase 1/2 mutated acute myeloid leukemia ; volume:38 ; number:5 ; day:10 ; month:4 ; year:2024 ; pages:927-935 ; date:5.2024
Leukemia ; 38, Heft 5 (10.4.2024), 927-935, 5.2024
- Urheber
-
Fruchtman, Harry
Avigan, Zachary M.
Waksal, Julian A.
Brennan, Nicole
Mascarenhas, John O.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41375-024-02246-2
- URN
-
urn:nbn:de:101:1-2407152117174.832437471757
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Fruchtman, Harry
- Avigan, Zachary M.
- Waksal, Julian A.
- Brennan, Nicole
- Mascarenhas, John O.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Isocitrate dehydrogenase inhibitors in acute myeloid leukemia
Recurrent SETD2 mutation in NPM1-mutated acute myeloid leukemia
NPM1 -Mutated Acute Myeloid Leukemia: Recent Developments and Open Questions
What have we learned about TP53-mutated acute myeloid leukemia?
Monitoring Minimal Residual Disease in RUNX1 -Mutated Acute Myeloid Leukemia
Genomic characterization of clonal evolution in NPM1 mutated acute myeloid leukemia
Multi-omics analysis of DNMT3A- and NPM1-mutated acute myeloid leukemia
Risk factors affect accurate prognosis in ASXL1-mutated acute myeloid leukemia
Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemia
Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemia
Functional characterisation of mutant isocitrate dehydrogenase in acute myeloid leukemia
Elucidating the role of isocitrate dehydrogenase 3 in acute myeloid leukemia
Isocitrate dehydrogenase inhibitors in acute myeloid leukemia
Recurrent SETD2 mutation in NPM1-mutated acute myeloid leukemia
NPM1 -Mutated Acute Myeloid Leukemia: Recent Developments and Open Questions
What have we learned about TP53-mutated acute myeloid leukemia?
Monitoring Minimal Residual Disease in RUNX1 -Mutated Acute Myeloid Leukemia
Genomic characterization of clonal evolution in NPM1 mutated acute myeloid leukemia
Multi-omics analysis of DNMT3A- and NPM1-mutated acute myeloid leukemia
Risk factors affect accurate prognosis in ASXL1-mutated acute myeloid leukemia
Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemia
Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemia
Functional characterisation of mutant isocitrate dehydrogenase in acute myeloid leukemia
Elucidating the role of isocitrate dehydrogenase 3 in acute myeloid leukemia
Isocitrate dehydrogenase inhibitors in acute myeloid leukemia
Recurrent SETD2 mutation in NPM1-mutated acute myeloid leukemia
NPM1 -Mutated Acute Myeloid Leukemia: Recent Developments and Open Questions
What have we learned about TP53-mutated acute myeloid leukemia?
Monitoring Minimal Residual Disease in RUNX1 -Mutated Acute Myeloid Leukemia
Genomic characterization of clonal evolution in NPM1 mutated acute myeloid leukemia
Multi-omics analysis of DNMT3A- and NPM1-mutated acute myeloid leukemia
Risk factors affect accurate prognosis in ASXL1-mutated acute myeloid leukemia
Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemia
Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemia
Functional characterisation of mutant isocitrate dehydrogenase in acute myeloid leukemia